(Q43137475)

14 November 2017

Impulsive-compulsive spectrum behaviors in pathologically confirmed progressive supranuclear palsy (English)

1 reference

14 November 2017

2

1 reference

14 November 2017

8

Andrew J Lees

1 reference

14 November 2017

4

Andrew H Evans

1 reference

14 November 2017

1

Sean S O'Sullivan

1 reference

14 November 2017

6

Janice L Holton

1 reference

14 November 2017

Zeshan Ahmed

3

1 reference

14 November 2017

Andrew D Lawrence

series ordinal

5

1 reference

14 November 2017

Tamas Revesz

series ordinal

7

1 reference

14 November 2017

language of work or name

English

0 references

publication date

1 April 2010

1 reference

14 November 2017

1 reference

14 November 2017

25

1 reference

14 November 2017

5

1 reference

14 November 2017

638-642

1 reference

Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome.

14 November 2017

1 reference

Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management

21 January 2018

1 reference

Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists

21 January 2018

1 reference

Punding in patients on dopamine agonists for restless leg syndrome

21 January 2018

1 reference

Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy

21 January 2018

1 reference

Dopamine dysregulation syndrome in a patient with restless legs syndrome.

21 January 2018

1 reference

Drug hoarding: a case of atypical dopamine dysregulation syndrome in a RLS patient

21 January 2018

1 reference

The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service

21 January 2018

1 reference

Comparison of motor, cognitive, and behavioral features in progressive supranuclear palsy and Parkinson's disease

21 January 2018

1 reference

Cognitive dysfunctions and pathological gambling in patients with Parkinson's disease.

21 January 2018

1 reference

Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease.

21 January 2018

1 reference

Pathological gambling in Parkinson's disease: risk factors and differences from dopamine dysregulation. An analysis of published case series.

21 January 2018

1 reference

Pathological gambling caused by drugs used to treat Parkinson disease

21 January 2018

1 reference

Dopaminergic and cholinergic lesions in progressive supranuclear palsy

21 January 2018

1 reference

Basal ganglia cholinergic and dopaminergic function in progressive supranuclear palsy.

21 January 2018

1 reference

Prevalence of repetitive and reward-seeking behaviors in Parkinson disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MDS.22902

1 reference

14 November 2017

1 reference